ADVANCED MEDICAL SOLUTIONS GROUP PLC — M&A Activity 2026

Apr 29, 2026

National Storage Mechanism | Additional information

RNS Number : 2971C

Advanced Medical Solutions Grp PLC

29 April 2026

FORM 8 (OPD)

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

1.         KEY INFORMATION

(a) Full name of discloser:	Advanced Medical Solutions Group PLC
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):      The naming of nominee or vehicle companies is insufficient.  For a trust, the trustee(s), settlor and beneficiaries must be named.	N/A
(c) Name of offeror/offeree in relation to whose relevant securities this form relates:      Use a separate form for each offeror/offeree	Advanced Medical Solutions Group PLC
(d) Is the discloser the offeror or the offeree?	Offeree
(e) Date position held:      The latest practicable date prior to the disclosure	28 April 2026
(f)  In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?      If it is a cash offer or possible cash offer, state "N/A"	N/A

2.         POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

Class of relevant security:	Ordinary Shares of 5 pence each
	Interests		Short positions
Number	%	Number	%
(1) Relevant securities owned and/or controlled:	Nil	Nil	Nil	Nil
(2) Cash-settled derivatives:	Nil	Nil	Nil	Nil
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:	Nil	Nil	Nil	Nil
TOTAL:	Nil	Nil	Nil	Nil

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

(b)        Rights to subscribe for new securities

Class of relevant security in relation to which subscription right exists:	None
Details, including nature of the rights concerned and relevant percentages:	None

3.         POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

Interests of directors

Advanced Medical Solutions Group PLC ordinary shares held by directors of Advanced Medical Solutions Group PLC:

Name	Number of AMS Shares	Percentage of AMS existing issued ordinary share capital
Christopher Meredith Edward Johnson Grahame Cook Susan Searle	1,856,4331 313,4982 48,864 10,0003	0.84% 0.14% 0.022% 0.0045%

1 Includes 1,389,815 shares held by Christopher Meredith's close relatives.

2 Includes 28,084 shares held by Edward Johnson's close relative.

3 Includes 5,000 shares held by Susan Searle's close relative.

Interests held as options or awards by directors of Advanced Medical Solutions Group PLC in ordinary shares of Advanced Medical Solutions Group PLC:

(A)        Christopher Meredith

(i)         Employee Share Purchase Plan

No. of Advanced Medical Solutions Group Plc ordinary shares of which options granted / subject to award	Date of grant	Vesting date	Expiry date	Exercise price (£)
28,060	12/05/2022	12/05/2022	-	Nil
13,143	17/05/2023	17/05/2023	-	Nil
26,286	17/05/2023	17/05/2026	-	Nil
25,288	11/11/2024	11/11/2024	-	Nil
50,576	11/11/2024	11/11/2027	-	Nil
32,168	13/05/2025	13/05/2025	-	Nil
64,336	13/05/2025	13/05/2028	-	Nil

(ii)        Share Incentive Plan

No. of Advanced Medical Solutions Group Plc ordinary shares of which options granted / subject to award	Date of grant	Vesting date	Expiry date	Exercise price (£)
586	30/04/2018	30/04/2018	-	Nil
586	30/04/2018	30/04/2021	-	Nil
545	29/04/2019	29/04/2019	-	Nil
545	29/04/2019	29/04/2022	-	Nil
734	05/05/2020	05/05/2020	-	Nil
734	05/05/2020	05/05/2023	-	Nil
661	11/05/2021	11/05/2021	-	Nil
661	11/05/2021	11/05/2024	-	Nil
665	12/05/2022	12/05/2022	-	Nil
665	12/05/2022	12/05/2025	-	Nil
716	17/05/2023	17/05/2023	-	Nil
1,432	17/05/2023	17/05/2026	-	Nil
801	11/11/2024	11/11/2024	-	Nil
1,602	11/11/2024	11/11/2027	-	Nil
923	13/05/2025	13/05/2025	-	Nil
1,846	13/05/2025	13/05/2028	-	Nil

(iii)       Long Term Incentive Plan

No. of Advanced Medical Solutions Group Plc ordinary shares of which options granted / subject to award	Date of grant	Vesting date	Expiry date	Exercise price (£)
150,199	14/04/2022	14/04/2025	14/04/2032	Nil
216,320	14/04/2023	14/04/2026	14/04/2033	Nil
411,478	23/04/2024	23/04/2027	23/04/2034	Nil
438,194	30/04/2025	30/04/2028	30/04/2035	Nil
422,941	03/04/2026	03/04/2029	03/04/2036	Nil

(iv)       Deferred Bonus Plan

No. of Advanced Medical Solutions Group Plc ordinary shares of which options granted / subject to award	Date of grant	Vesting date	Expiry date	Exercise price (£)
6,219	14/04/2022	14/04/2025	14/04/2032	Nil
31,138	14/04/2023	14/04/2026	14/04/2033	Nil

(B)        Edward Johnson

(i)         Employee Share Purchase Plan

No. of Advanced Medical Solutions Group Plc ordinary shares of which options granted / subject to award	Date of grant	Vesting date	Expiry date	Exercise price (£)
8,201	03/05/2016	03/05/2016	-	Nil
6,476	02/05/2017	02/05/2017	-	Nil
6,259	30/04/2018	30/04/2018	-	Nil
3,302	29/04/2019	29/04/2019	-	Nil
9,830	05/05/2020	05/05/2020	-	Nil
8,945	11/05/2021	11/05/2021	-	Nil
19,252	17/05/2023	17/05/2023	-	Nil
38,504	17/05/2023	17/05/2026	-	Nil
16,428	11/11/2024	11/11/2024	-	Nil
32,856	11/11/2024	11/11/2027	-	Nil
20,669	13/05/2025	13/05/2025	-	Nil
41,338	13/05/2025	13/05/2028	-	Nil

(ii)        Share Incentive Plan

No. of Advanced Medical Solutions Group Plc ordinary shares of which options granted / subject to award	Date of grant	Vesting date	Expiry date	Exercise price (£)
1,428	30/04/2014	30/04/2014	-	Nil
1,428	30/04/2014	30/04/2017	-	Nil
1,271	29/04/2015	29/04/2015	-	Nil
1,271	29/04/2015	29/04/2018	-	Nil
983	03/05/2016	03/05/2016	-	Nil
983	03/05/2016	03/05/2019	-	Nil
681	02/05/2017	02/05/2017	-	Nil
681	02/05/2017	02/05/2020	-	Nil
586	30/04/2018	30/04/2018	-	Nil
586	30/04/2018	30/04/2021	-	Nil
545	29/04/2019	29/04/2019	-	Nil
545	29/04/2019	29/04/2022	-	Nil
734	05/05/2020	05/05/2020	-	Nil
734	05/05/2020	05/05/2023	-	Nil
661	11/05/2021	11/05/2021	-	Nil
661	11/05/2021	11/05/2024	-	Nil
665	12/05/2022	12/05/2022	-	Nil
665	12/05/2022	12/05/2025	-	Nil
716	17/05/2023	17/05/2023	-	Nil
1,432	17/05/2023	17/05/2026	-	Nil
801	11/11/2024	11/11/2024	-	Nil
1,602	11/11/2024	11/11/2027	-	Nil
923	13/05/2025	13/05/2025	-	Nil
1,846	13/05/2025	13/05/2028	-	Nil

(iii)       Long Term Incentive Plan

No. of Advanced Medical Solutions Group Plc ordinary shares of which options granted / subject to award	Date of grant	Vesting date	Expiry date	Exercise price (£)
56,324	14/04/2022	14/04/2025	14/04/2032	Nil
89,285	14/04/2023	14/04/2026	14/04/2033	Nil
169,837	23/04/2024	23/04/2027	23/04/2034	Nil
180,864	30/04/2025	30/04/2028	30/04/2035	Nil
174,568	03/04/2026	03/04/2029	03/04/2036	Nil

(iv)       Deferred Bonus Plan

No. of Advanced Medical Solutions Group Plc ordinary shares of which options granted / subject to award	Date of grant	Vesting date	Expiry date	Exercise price (£)
13,528	14/04/2023	14/04/2026	14/04/2033	Nil

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

4.         OTHER INFORMATION

(a)        Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"
None

(b)        Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to: (i)  the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state "none"
None

(c)        Attachments

Are any Supplemental Forms attached?

Supplemental Form 8 (Open Positions)	No
Supplemental Form 8 (SBL)	No

###### Date of disclosure:	29 April 2026
###### Contact name:	Owen Bromley, Company Secretary
###### Telephone number:	01606 545514

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

FEEEAELPADSKEAA